Cargando…
Human papillomavirus vaccination: the population impact
We currently have the knowledge and experience to prevent much of human papillomavirus (HPV)-related disease burden globally. In many countries where prophylactic HPV vaccination programs have been adopted as highly effective public health programs with good vaccine coverage, we are already seeing,...
Autores principales: | Lee, Lai-yang, Garland, Suzanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473416/ https://www.ncbi.nlm.nih.gov/pubmed/28663791 http://dx.doi.org/10.12688/f1000research.10691.1 |
Ejemplares similares
-
Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus
por: Toh, Zheng Quan, et al.
Publicado: (2019) -
Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011) -
Australia’s Role in Pneumococcal and Human Papillomavirus Vaccine Evaluation in Asia-Pacific
por: Toh, Zheng Quan, et al.
Publicado: (2021) -
Human Papillomavirus Vaccination After COVID-19
por: Toh, Zheng Quan, et al.
Publicado: (2021) -
Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience
por: Garland, Suzanne M., et al.
Publicado: (2016)